
Acrivon Therapeutics Inc (ACRV) EPS is poised to hit -0.57 next quarter: How Investors Can Make It Count the Most?
As on Wednesday, Acrivon Therapeutics Inc (NASDAQ: ACRV) got off with the flyer as it spiked 6.03% to $1.23, before settling in for the price